Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 201–300 of 1,002
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation
Rivers‐Auty, J., Tapia, V. S., White, C., Daniels, M. J. D., Drinkall, S., Kennedy, P. T., Spence, H. G., Yu, S., Green, J., Hoyle, C., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1980-20.2020 · Cited by 93
“…is activated by zinc deficiency (Summersgill et al., 2014), we hypothesized that accelerated memory impairment in the APP/PS1 mice on the ZD diet is because of a periplaque nlrp3 response (Heneka et al., 2013; Daniels et al., 2016; Dempsey et al., 2017; Venegas et al., 2017; White et al., 2017).”
BackgroundZhao, Y., Zheng, Q., Hong, Y., Gao, Y., Hu, J., Lang, M., Zhang, H., Zhou, Y., Luo, H., Zhang, X., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01352-1 · Cited by 89
Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
Marttinen, M., Takalo, M., Natunen, T., Wittrahm, R., Gabbouj, S., Kemppainen, S., Leinonen, V., Tanila, H., Haapasalo, A., & Hiltunen, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00963 · Cited by 88
Alsema, A. M., Jiang, Q., Kracht, L., Gerrits, E., Dubbelaar, M. L., Miedema, A., Brouwer, N., Hol, E. M., Middeldorp, J., van Dijk, R., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00134 · Cited by 84
“Several studies claim that CXCR2 could augment AD pathology in mouse models and that deficiency in CXCR2 decreases amyloid-beta deposition (Xia and Hyman, 2002; Bakshi et al., 2011; Veenstra and Ransohoff, 2012; Ryu et al., 2015).”
BackgroundMicrovascular Alterations in Alzheimer's Disease
Steinman, J., Sun, H.-S., & Feng, Z.-P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.618986 · Cited by 81
“The ASC specks may be absorbed by myeloid cells, resulting in sustained immunoactivity (Venegas et al., 2017).”
BackgroundCell death–mediated cytokine release and its therapeutic implications
Place, D. E., & Kanneganti, T.-D. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181892 · Cited by 84
Pirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 88
Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83
Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
Lee, E., Eo, J.-C., Lee, C., & Yu, J.-W. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0060 · Cited by 71
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
Bulté, D., Rigamonti, C., Romano, A., & Mortellaro, A. (2023) · Cells · doi:10.3390/cells12131766 · Cited by 84
TREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
Litwiniuk, A., Bik, W., Kalisz, M., & Baranowska-Bik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115603 · Cited by 82
“In turn, accumulation and deposition of Aβ as well as NFT formation caused the release of mature IL-1β via activation of NLRP3 in microglia [136,142,143].”
BackgroundHochheiser, I. V., Behrmann, H., Hagelueken, G., Rodríguez-Alcázar, J. F., Kopp, A., Latz, E., Behrmann, E., & Geyer, M. (2022) · Science Advances · doi:10.1126/sciadv.abn7583 · Cited by 91
Self-citationCognitive dysfunction following COVID-19 infection
Hadad, R., Khoury, J., Stanger, C., Fisher, T., Schneer, S., Ben‐Hayun, R., Possin, K. L., Valcour, V., Aharon‐Peretz, J., & Adir, Y. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-022-01079-y · Cited by 86
Chen, K., Wang, H., Ilyas, I., Mahmood, A., & Hou, L. (2023) · Brain Sciences · doi:10.3390/brainsci13040634 · Cited by 90
“A recent discovery and breakthrough suggest that both the innate immune system and microglia are important for synaptic lopping which describes their contribution in imparting changes to the neurons that surrounds them [32].”
BackgroundImmune Activation in Alzheimer Disease
Mary, A., Mancuso, R., & Heneka, M. T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-035222 · Cited by 85
Self-citationPolygala saponins inhibit NLRP3 inflammasome-mediated neuroinflammation via SHP-2-Mediated mitophagy
Qiu, W.-Q., Ai, W., Zhu, F.-D., Zhang, Y., Guo, M.-S., Law, B. Y.-K., Wu, J.-M., Wong, V. K.-W., Tang, Y., Yu, L., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.263 · Cited by 77
Targeting NLRP3 inflammasome for neurodegenerative disorders
Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 86
McManus, R. M., Komes, M. P., Griep, A., Santarelli, F., Schwartz, S., Perea, J. R., Schlachetzki, J. C. M., Bouvier, D. S., Khalil, M., Lauterbach, M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.01.007 · Cited by 84
Self-citationRui, W., Xiao, H., Fan, Y., Ma, Z., Xiao, M., Li, S., & Shi, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02329-2 · Cited by 97
“Moreover, ASC or NLRP3 knockout decreases Aβ deposition and neurofibrillary tangle formation in transgenic AD mice [37, 38].”
BackgroundHuang, Q., Jiang, C., Xia, X., Wang, Y., Yan, C., Wang, X., Lei, T., Yang, X., Yang, W., Cheng, G., et al. (2023) · Research · doi:10.34133/research.0180 · Cited by 78
“Specifically, the accumulated Aβ plaques impair phagocytic function of microglia and transform microglia to a pro-inflammatory M1 phenotype, resulting in overproduction of ROS and various inflammatory factors [35,36], which, in turn, undoubtedly promote the production and aggregation of Aβ [37,38].”
BackgroundQiu, W.-Q., Pan, R., Tang, Y., Zhou, X.-G., Wu, J.-M., Yu, L., Law, B. Y.-K., Ai, W., Yu, C.-L., Qin, D.-L., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110575 · Cited by 76
Shen, Z., Bao, X., & Wang, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00314 · Cited by 77
“In recent years, an increasing number of studies have recognized that neuroinflammation, mainly driven by activated microglia, also contributes to AD pathogenesis (Calsolaro and Edison, 2016; Ransohoff, 2016a; Bolos et al., 2017; Mathys et al., 2017; Venegas et al., 2017).”
BackgroundWhat are activated and reactive glia and what is their role in neurodegeneration?
Bennett, M. L., & Viaene, A. N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105172 · Cited by 77
Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 81
Fruhwürth, S., Zetterberg, H., & Paludan, S. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578342 · Cited by 74
“It has further been shown that ASC-specks can act as nucleation sites for A β to further aggregate and fibrilize (Venegas et al., 2017).”
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
Yang, Y., & Zhang, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00110 · Cited by 77
“At present, ASC specks, which act as the receptor of inflammasome, are considered to be responsible for Aβ dissemination (Halle et al., 2008; Freeman et al., 2017; Venegas et al., 2017).”
BackgroundZhang, Z., Bai, H., Ma, X., Shen, M., Li, R., Qiu, D., Li, S., & Gao, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02295-9 · Cited by 77
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 78
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 80
Parodi-Rullán, R. M., Javadov, S., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 73
“Additionally, the release of ASC specks from microglia has been shown to increase amyloid aggregation [187] suggesting that the NLRP3 is not only involved in the activation of inflammation, but also plays a role in Aβ deposition.”
BackgroundBanerjee, S., Ghosh, S., Mandal, A., Ghosh, N., & Sil, P. C. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02801-7 · Cited by 76
“Inflammasome is a multiprotein complex consisting of an adaptor, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain), and pro-caspase-1 (Evavold and Kagan 2019).”
BackgroundInfluentialInflammasome activation in traumatic brain injury and Alzheimer's disease
Johnson, N. H., Vaccari, J. P. D. R., Bramlett, H. M., Keane, R. W., & Dietrich, W. D. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.014 · Cited by 77
“Likewise, similar observations have been observed in and are thought to contribute to the progression of AD pathology.(13,69,99,105) Experiments involving TBI have observed increased levels of AD-associated proteins after injury, and human observations suggest that about 30% of TBI patients develop Aβ after injury.”
BackgroundEnriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
Xu, H., Rajsombath, M. M., Weikop, P., & Selkoe, D. J. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201808931 · Cited by 74
The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
Stancu, I. C., Lodder, C., Botella Lucena, P., Vanherle, S., Gutiérrez de Ravé, M., Terwel, D., Bottelbergs, A., & Dewachter, I. (2022) · Glia · doi:10.1002/glia.24160 · Cited by 72
The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
Batista, A. F., Khan, K. A., Papavergi, M.-T., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020817 · Cited by 65
Microbiota‐microglia connections in age‐related cognition decline
Zhou, R., Qian, S., Cho, W. C. S., Zhou, J., Jin, C., Zhong, Y., Wang, J., Zhang, X., Xu, Z., Tian, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13599 · Cited by 71
Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
Sun, Z., Zhang, X., So, K.-F., Jiang, W., & Chiu, K. (2024) · Biomolecules · doi:10.3390/biom14070833 · Cited by 71
“An antibody neutralizing extracellular ASC ameliorates amyloid burden, blocks inflammasome activation, and mitigates potential deleterious inflammatory processes [120].”
BackgroundInfluentiald’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 79
“Relevant to our discussion, the immune system is activated (early) in AD, and may contribute, by means of ineffective clearance of Aβ and tau by the microglia, to the diffusion of such pathology to neighboring or connected areas [77,78], and inflammation per se is a trigger”
BackgroundZhang, F., Deng, Y., Wang, H., Fu, J., Wu, G., Duan, Z., Zhang, X., Cai, Y., Zhou, H., Yin, J., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.021 · Cited by 78
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
Kaji, S., Maki, T., Ishimoto, T., Yamakado, H., & Takahashi, R. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-0185-5 · Cited by 70
“Given the crucial roles of the NLRP3-ASC inflammasome in amyloid β (Aβ)- and tau-induced microglia on accumulation and propagation of Aβ and tau [160, 161], reactive microglia with a high migratory capacity in α-syn pathology may also accelerate development of α-syn aggregates and spread via uptake and re-release of α…”
BackgroundThe Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer’s Disease
Scott, X. O., Stephens, M. E., Desir, M. C., Dietrich, W. D., Keane, R. W., & de Rivero Vaccari, J. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134674 · Cited by 68
“In addition, we will measure the protein levels of ASC, Aβ, T-tau and phospho-tau in the CSF to better understand the relationship between ASC and Aβ, since these two proteins form a complex that is detrimental in mice [26,27].”
BackgroundInfluentialMicroglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
The role of midkine in health and disease
Neumaier, E. E., Rothhammer, V., & Linnerbauer, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1310094 · Cited by 77
“While AD is not considered a primary in fl ammatory disorder, it has become increasingly clear that secondary in fl ammation is a key driver of disease progression (96, 97).”
BackgroundBartolotti, N., & Lazarov, O. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.004 · Cited by 74
“Recent evidence suggests that inflammasomes may respond to, as well as exacerbate, AD pathology, potentially resulting in a cycle of increased inflammation and increased pathology, thus emphasizing the contribution of the immune system to AD pathogenesis (Venegas et al., 2017).”
BackgroundInhibition of the NLRP3 inflammasome by HSP90 inhibitors
Nizami, S., Arunasalam, K., Green, J., Cook, J., Lawrence, C. B., Zarganes‐Tzitzikas, T., Davis, J. B., Daniel, E. D., & Brough, D. (2020) · Immunology · doi:10.1111/imm.13267 · Cited by 70
Cao, S., Fisher, D. W., Rodriguez, G., Yu, T., & Dong, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02054-2 · Cited by 69
Neuroimmune cleanup crews in brain injury
Bolte, A. C., & Lukens, J. R. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.04.003 · Cited by 71
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 72
Zhang, H., Jiang, W., Zhao, Y., Song, T., Xi, Y., Han, G., Jin, Y., Song, M., Bai, K., Zhou, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00191 · Cited by 65
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Cai, W., Wu, T., & Chen, N. (2023) · Biomolecules · doi:10.3390/biom13020313 · Cited by 61
“ASC released from microglia can rapidly bind to Aβ and stimulate the production of Aβ oligomers and aggregates, thereby exacerbating the progression of AD [66].”
BackgroundJiang, Y., Liu, H., Green, J., Blevins, H., Guo, C., Patel, S., Halquist, M. S., McRae, M., Venitz, J., Wang, X., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01155 · Cited by 70
Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
Zhang, X., Liu, W., Zan, J., Wu, C., & Tan, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-71510-z · Cited by 68
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
“Moreover, Aβ fibrils can themselves stimulate inflammasome formation and this raises the intriguing possibility that Aβ fibrils promote Aβ aggregation via microglia activation, resulting in a vicious cycle (Halle et al., 2008; Heneka et al., 2013; Venegas et al., 2017; Friker et al., 2020).”
BackgroundInfluentialInflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice
Tzeng, T.-C., Hasegawa, Y., Iguchi, R., Cheung, A., Caffrey, D. R., Thatcher, E. J., Mao, W., Germain, G., Tamburro, N. D., Okabe, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801802115 · Cited by 67
“Inflammasome complexes seem to play a critical role in the spreading of Aβ pathology within and between brain areas (8).”
BackgroundSelf-citationPositive Feedback Loops in Alzheimer’s Disease: The Alzheimer’s Feedback Hypothesis
Doig, A. J. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180583 · Cited by 62
Brain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease
Brioschi, S., Zhou, Y., & Colonna, M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900821 · Cited by 68
“microglia during amyloid and Tau pathology (168, 169).”
BackgroundLiu, P., Zhou, Y., Shi, J.-Z., Wang, F., Yang, X., Zheng, X., Wang, Y., He, Y., Xie, X., & Pang, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154801 · Cited by 71
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases
Ahn, M., Chen, V. C.-W., Rozario, P., Ng, W. L., Kong, P. S., Sia, W. R., Kang, A. E. Z., Su, Q., Nguyen, L. H., Zhu, F., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.036 · Cited by 68
Update of inflammasome activation in microglia/macrophage in aging and aging‐related disease
Hu, M., Lin, Y., Zhang, B., Lu, D., Lu, Z., & Cai, W. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13262 · Cited by 69
Reformulating Pro-Oxidant Microglia in Neurodegeneration
García-Revilla, J., Alonso-Bellido, I. M., Burguillos, M. A., Herrera, A. J., Espinosa-Oliva, A. M., Ruiz, R., Cruz-Hernández, L., García-Domínguez, I., Roca-Ceballos, M. A., Santiago, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101719 · Cited by 62
“In fact, inflammasome formation may exacerbate AD pathology through microglia release of ASC specks that promote Aβ cross-seeding [145].”
BackgroundChu, F., Tan, R., Wang, X., Zhou, X., Ma, R., Ma, X., Li, Y., Liu, R., Zhang, C., Liu, X., et al. (2023) · Research · doi:10.34133/research.0130 · Cited by 79
“Microglia display M1 and M2 phenotypic characteristics according to whether they express pro- or anti-inflammatory factors [41], and overactivation of M1 microglia accelerates to the spread of Aβ, which in turn promotes the differentiation of microglia to the M1 phenotype, leading to an imbalance in microglia polariza…”
BackgroundChoi, S.-B., Kwon, S., Kim, J.-H., Ahn, N.-H., Lee, J.-H., & Yang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411757 · Cited by 73
“Extracellular ASC specks progressively bind with Aβ deposits in the AD transgenic mouse model [78].”
BackgroundLv, Z., Chen, L., Chen, P., Peng, H., Rong, Y., Hong, W., Zhou, Q., Li, N., Li, B., Paolicelli, R. C., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.003 · Cited by 69
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
Wu, X., Wan, T., Gao, X., Fu, M., Duan, Y., Shen, X., & Guo, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.922331 · Cited by 66
“In the development of Alzheimer’s disease (AD), the caspase activation and recruitment domain (CARD/ASC)-containing bridging proteins released bymicroglia pyroptosis rapidly bind to Aβ and increase the formation of Aβ oligomers and aggregates (Venegas et al., 2017).”
BackgroundFaridar, A., Vasquez, M., Thome, A. D., Yin, Z., Xuan, H., Wang, J. H., Wen, S., Li, X., Thonhoff, J. R., Zhao, W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01447-z · Cited by 72
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 72
“…of many inflammatory pathways (e.g., NOD-like receptor family and pyrin structural domain 3-containing (NLRP3) inflammatory vesicles), increasing the release of pro-inflammatory cytokines and accelerating neurodegeneration (Venegas et al., 2017; Mata-Martínez et al., 2022; Merighi et al., 2022).”
BackgroundExercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 67
“Given the toxic nature of soluble amyloid species, this process may be helpful by depositing amyloid [129].”
BackgroundHulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 66
“Immunohistochemical studies revealed that ASC specks were found in the core of extracellular Aβ plaques in APP/PS1 mouse models as early as 4-months as well as in human AD patients including the early mild cognitive impairment stages of AD (Venegas et al., 2017).”
BackgroundResultInfluentialThe Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62
“This group has shown recently an association between ALS and the immune system, particularly the glia, microglia and regulatory T (T-reg) lymphocytes, which are of particular interest in ALS and other neurodegenerative disorders [11].”
Background(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02138-6 · Cited by 62
Self-citationZhang, Z., Tan, Q., Guo, P., Huang, S., Jia, Z., Liu, X. B., Feng, H., & Chen, Y. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02530-x · Cited by 66
Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 66
Jiao, Y., Nan, J., Mu, B., Zhang, Y., Zhou, N., Yang, S., Zhang, S., Lin, W.-T., Wang, F., Xia, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114194 · Cited by 62
Role of pyroptosis in the pathogenesis and treatment of diseases
Jin, X., Ma, Y., Liu, D., & Huang, Y. (2023) · MedComm · doi:10.1002/mco2.249 · Cited by 66
Wang, H., Xu, X., Pan, Y., Yan, Y., Hu, X., Chen, R., Ravoo, B. J., Guo, D., & Zhang, T. (2020) · Advanced Materials · doi:10.1002/adma.202006483 · Cited by 65
Lee, J., Kim, H., Kim, J., Yook, T., Kim, K., Lee, J., & Yang, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031324 · Cited by 58
“However, it was not possible to induce the spread of Aβ pathology in ASC‐deficient APP/PS1 mice [22].”
BackgroundWang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03166-9 · Cited by 60
Levites, Y., Dammer, E. B., Ran, Y., Tsering, W., Duong, D., Abreha, M., Gadhavi, J., Lolo, K., Trejo-Lopez, J., Phillips, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101669 · Cited by 56
Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease
Song, M., Zhao, X., & Song, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02248-y · Cited by 60
Food‐Origin Mycotoxin‐Induced Neurotoxicity: Intend to Break the Rules of Neuroglia Cells
Pei, X., Zhang, W., Jiang, H., Liu, D., Liu, X., Li, L., Li, C., Xiao, X., Tang, S., & Li, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9967334 · Cited by 61
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
Chen, C., Zhou, Y., Ning, X., Li, S., Xue, D., Wei, C., Zhu, Z., Sheng, L., Lu, B., Li, Y., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02682-w · Cited by 62
González-Rodríguez, M., Villar‐Conde, S., Astillero‐Lopez, V., Villanueva‐Anguita, P., Úbeda‐Bañón, I., Flores‐Cuadrado, A., Martínez-Marcos, A., & Saiz‐Sánchez, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010165 · Cited by 63
Chow, Y. C., Yam, H. C., Gunasekaran, B., Lai, W. Y., Wo, W. Y., Agarwal, T., Ong, Y. Y., Cheong, S. L., & Tan, S.-A. S. W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.987683 · Cited by 63
“Of note, the activation of NLRP3 inflammasome in microglia and ASC specks initiates amyloid-b assembly and deposition (Venegas et al., 2017).”
BackgroundMicroglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease
Li, Y., Chen, X., Zhou, M., Feng, S., Peng, X., & Wang, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230273 · Cited by 62
Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases
Rashidi, M., Wicks, I. P., & Vince, J. E. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.06.005 · Cited by 60
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
Koh, H., Lee, S., Lee, H., Min, J.-W., Iwatsubo, T., Teunissen, C., Cho, H.-J., & Ryu, J.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313136 · Cited by 53
Vontell, R. T., de Rivero Vaccari, J. P., Sun, X., Gultekin, S. H., Bramlett, H. M., Dietrich, W. D., & Keane, R. W. (2023) · Brain Pathology · doi:10.1111/bpa.13142 · Cited by 57
Hung, W., Ho, C., & Pan, M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900550 · Cited by 65
Fernando, K. K. M., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Cordaro, M., Salinaro, A. T., Siracusa, R., D’Amico, R., Impellizzeri, D., Scuto, M., Ontario, M. L., Cuzzocrea, S., Di Paola, R., Fusco, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10111664 · Cited by 55
Friedland, R. P., McMillan, J. D., & Kurlawala, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051652 · Cited by 56
Li, J., Zhao, R., Jiang, Y., Xu, Y., Zhao, H., Lyu, X., & Wu, T. (2020) · Food & Function · doi:10.1039/c9fo02103e · Cited by 58
Microglial Immunometabolism in Alzheimer’s Disease
Shippy, D. C., & Ulland, T. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.563446 · Cited by 54
“Of further interest are the number of recent studies which suggest the nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is activated by glycolytic enzymes (Hughes and O’Neill, 2018); activation of the NLRP3 inflammasome has been demonstrated to contribute to AD pathology (Heneka et al., 2013; Ve…”
BackgroundKalinin, S., González‐Prieto, M., Scheiblich, H., Lisi, L., Kusumo, H., Heneka, M. T., Madrigal, J. L. M., Pandey, S. C., & Feinstein, D. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1184-7 · Cited by 56
Self-citationCytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Lau, S.-F., Fu, A. K. Y., & Ip, N. Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03810-0 · Cited by 52
“Second, activated microglia can secrete ASC, a component of NLRP3 inflammasome, to bind and cross-seed Aβ peptides to form Aβ plaques [44].”
BackgroundAstillero‐Lopez, V., Villar‐Conde, S., González-Rodríguez, M., Flores‐Cuadrado, A., Úbeda‐Bañón, I., Saiz‐Sánchez, D., & Martínez-Marcos, A. (2024) · Brain Pathology · doi:10.1111/bpa.13235 · Cited by 59
Rossano, S. M., Johnson, A. S., Smith, A. P., Ziaggi, G., Roetman, A. E., Guzman, D., Okafor, A., Klein, J., Tomljanovic, Z., Stern, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13699 · Cited by 59
“…disease pathology and progression via cytokine release 9 and the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome, 2,11–17 preceding 13,14,18–20 and seeding 21–23 tau pathology to surrounding unaffected areas as well as contributing to amyloid-initiated, tau-dependent…”
BackgroundMicroglia in Neurodegenerative Disorders
Tejera, D., & Heneka, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_5 · Cited by 58
Self-citation
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.